Bayard Powell to Hydroxamic Acids
This is a "connection" page, showing publications Bayard Powell has written about Hydroxamic Acids.
Connection Strength
0.026
-
Walter RB, Medeiros BC, Powell BL, Schiffer CA, Appelbaum FR, Estey EH. Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia. Haematologica. 2012 May; 97(5):739-42.
Score: 0.026